Evaluation of the antibacterial synergism of two plant extracts belonging to Bignoniaceae family and development of a topical formulation

Abstract Fridericia caudigera and Cuspidaria convoluta (Bignoniaceae) species, which grow in the northwest of Argentina, have shown antibacterial effect against strains isolated from skin infections, and each one displayed synergism with commercial antibiotics. The aims of this work were to evaluate the antibacterial activity and toxicity of the combination of these two plant species, and to design a stable gel for topical use including the blend of extracts. The combination of extracts was evaluated for synergistic effects (chequerboard assay), genotoxicity (Ames test) and cytotoxicity (Artemia salina test). A gel was subsequently formulated with the combination of extracts using carboxymethylcellulose as a polymer. The following physico- chemical characteristics of the gel formulation: pH, viscosity, spreadability and total phenol content, as well as resistance to severe temperature changes, biological activity (diffusion in agar), in vitro permeation (Franz cells) and primary dermal irritation (Draize test) were analyzed. The combination of extracts showed a synergistic effect on pathogenic bacteria and was not toxic in the in vitro tests. The gel was stable and retained the antimicrobial activity of the original extracts. The formulation proposed in this work could constitute an alternative for primary skin infections since it proved to be safe for topical administration.

Evaluation of the Genotoxicity of Endodontic Materials for Deciduous Teeth Using the Comet Assay

ABSTRACT Objective: To evaluate genotoxicity of zinc oxide, P. A. calcium hydroxide, mineral trioxide aggregate and an iodoform paste using comet assay on human lymphocytes. Material and Methods: Two positive controls were used: methyl-methanesulfonate for the P.A. calcium hydroxide and mineral trioxide aggregate; and doxorubicin for the iodoform paste and zinc oxide. There were also two negative controls: distilled water for the P.A. calcium hydroxide and mineral trioxide aggregate; and DMSO for the iodoform paste and zinc oxide. Comets were identified using fluorescence microscopy and 100 of them were counted on each of the three slides analyzed per drug test. A damage index was established, taking into consideration the score pattern that had previously been determined from the size and intensity of the comet tail. Analysis of variance, followed by Tukey's test, was used to compare the means of the DNA damage indices. Results: The DNA damage index observed for mineral trioxide aggregate (7.08 to 8.58) and P.A. calcium hydroxide (6.50 to 8.33), which were similar to negative control index. On the other hand, damage index for zinc oxide (104.7 to 218.50) and iodoform paste (115.7 to 210.7) were similar to positive control index. Conclusion: Iodoform paste and zinc oxide showed genotoxicity at all concentrations used.

In vivo genotoxicity testing strategies: Report from the 7th International workshop on genotoxicity testing (IWGT).

The working group reached complete or majority agreement on many issues. Results from TGR and in vivo comet assays for 91 chemicals showed they have similar ability to detect in vivo genotoxicity per se with bacterial mutagens and Ames-positive carcinogens. TGR and comet assay results were not significantly different when compared with IARC Group 1, 2 A, and unclassified carcinogens. There were significantly more comet assay positive responses for Group 2B chemicals, and for IARC classified and unclassified carcinogens combined, which may be expected since mutation is a sub-set of genotoxicity. A liver comet assay combined with the bone marrow/blood micronucleus (MNviv) test would detect in vivo genotoxins that do not exhibit tissue-specific or site-of-contact effects, and is appropriate for routine in vivo genotoxicity testing. Generally for orally administered substances, a comet assay at only one site-of-contact GI tract tissue (stomach or duodenum/jejunum) is required. In MNviv tests, evidence of target tissue exposure can be obtained in a number of different ways, as recommended by ICH S2(R1) and EFSA (Hardy et al., 2017). Except for special cases the i.p. route is inappropriate for in vivo testing; for risk evaluations more weight should be given to data from a physiologically relevant administration route. The liver MN test is sufficiently validated for the development of an OECD guideline. However, the impact of dosing animals >6 weeks of age needs to be evaluated. The GI tract MN test shows promise but needs more validation for an OECD guideline. The Pig-a assay detects systemically available mutagens and is a valuable follow-up to in vitro positive results. A new freeze-thaw protocol provides more flexibility. Mutant reticulocyte and erythrocyte frequencies should both be determined. Preliminary data are available for the Pig-a assay in male rat germ cells which require validation including germ cell DNA mutation origin.

An automatable platform for genotoxicity testing of nanomaterials based on the fluorometric γ-H2AX assay reveals no genotoxicity of properly surface-shielded cadmium-based quantum dots.

The large number of nanomaterial-based applications emerging in the materials and life sciences and the foreseeable increasing use of these materials require methods that evaluate and characterize the toxic potential of these nanomaterials to keep safety risks to people and environment as low as possible. As nanomaterial toxicity is influenced by a variety of parameters like size, shape, chemical composition, and surface chemistry, high throughput screening (HTS) platforms are recommended for assessing cytotoxicity. Such platforms are not yet available for genotoxicity testing. Here, we present first results obtained for application-relevant nanomaterials using an automatable genotoxicity platform that relies on the quantification of the phosphorylated histone H2AX (γ-H2AX) for detecting DNA double strand breaks (DSBs) and the automated microscope system AKLIDES® for measuring integral fluorescence intensities at different excitation wavelengths. This platform is used to test the genotoxic potential of 30 nm-sized citrate-stabilized gold nanoparticles (Au-NPs) as well as micellar encapsulated iron oxide nanoparticles (FeOx-NPs) and different cadmium (Cd)-based semiconductor quantum dots (QDs), thereby also searching for positive and negative controls as reference materials. In addition, the influence of the QD shell composition on the genotoxic potential of these Cd-based QDs was studied, using CdSe cores as well as CdSe/CdS core/shell and CdSe/CdS/ZnS core/shell/shell QDs. Our results clearly revealed the genotoxicity of the Au-NPs and its absence in the FeOx-NPs. The genotoxicity of the Cd-QDs correlates with the shielding of their Cd-containing core, with the core/shell/shell architecture preventing genotoxicity risks. The fact that none of these nanomaterials showed cytotoxicity at the chosen particle concentrations in a conventional cell viability assay underlines the importance of genotoxicity studies to assess the hazardous potential of nanomaterials.

Determination of Phosphorylated Histone H2AX in Nanoparticle-Induced Genotoxic Studies.

DNA double-strand breaks (DSBs), one of the most severe lesions of DNA damage triggered by various genotoxic insults, can lead to chromosome change, genomic instability, and even tumorigenesis if not repaired efficiently. In response to DNA damage, histone H2AX molecules are rapidly phosphorylated at serine 139 near the site of DNA DSBs and form γ-H2AX foci. As an early important cellular event linked to DNA damage and repair, γ-H2AX is a highly sensitive biomarker for "monitoring" DNA damage and consequently is a useful tool in genetic toxicology screen. We and other researchers have used γ-H2AX as a marker to assess the potential genotoxic effects of some nanoparticles in vitro and in vivo. In this chapter, we describe several useful methods for γ-H2AX detection, which can be used to evaluate the potential genotoxic effects of nanoparticles.

Ortho-nitrobenzyl derivatives as potential anti-schistosomal agents

ABSTRACT In the search for new anti-schistosomal agents, a series of fifteen ortho-nitrobenzyl derivatives was assayed in vitro against both the schistosomulum (somule) and adult forms of Schistosoma mansoni. Compounds 8 and 12 showed significant activity against somules at low micromolar concentrations, but none was active against adults. The SAR demonstrated that the compounds most active against the parasite were mutagenic to the human cell line RKO-AS45-1 only at concentrations 10- to 40-fold higher than the worm-killing dose. Given their electrophilicity, compounds were also screened as inhibitors of the S. mansoni cysteine protease (cathepsin B1) in vitro. Amides 5 and 15 exhibited a modest inhibition activity with values of 55.7 and 50.6 % at 100 µM, respectively. The nitrobenzyl compounds evaluated in this work can be regarded as hits in the search for more active and safe anti-schistosomal agents.

Multi-endpoint biological monitoring in combined, carcinogenic occupational exposures.

We aimed to develop a relevant multi-endpoint biomonitoring system by studying different genotoxicity biomarkers in complex carcinogenic exposures under occupational situations. Altogether 109 workers were followed in five different workplaces. The combined carcinogenic exposures were monitored in the urine and peripheral blood samples using Ames mutagenicity test and cytogenetic analyzes. The different genotoxicity endpoints studied showed different results in the same carcinogenic exposure situations. The urinary mutagenicity tests provided more information and proved to be more sensitive compared to the cytogenetic tests in the majority of cases. In complex exposures multistep biomonitoring panel should be applied, because the exact mechanisms of the combination of single exposing agents are not known. Such a panel should involve monitoring different endpoints, e.g. point mutations, chromosomal mutations. A relatively affordable and rapid testing panel was developed using validated tests as Ames and cytogenetic assays, but its practical use should be confirmed by further investigations.

RF-EMF exposure at 1800 MHz did not elicit DNA damage or abnormal cellular behaviors in different neurogenic cells.

Despite many years of studies, the debate on genotoxic effects of radiofrequency electromagnetic fields (RF-EMF) continues. To systematically evaluate genotoxicity of RF-EMF, this study examined effects of RF-EMF on DNA damage and cellular behavior in different neurogenic cells. Neurogenic A172, U251, and SH-SY5Y cells were intermittently (5 min on/10 min off) exposed to 1800 MHz RF-EMF at an average specific absorption rate (SAR) of 4.0 W/kg for 1, 6, or 24 h. DNA damage was evaluated by quantification of γH2AX foci, an early marker of DNA double-strand breaks. Cell cycle progression, cell proliferation, and cell viability were examined by flow cytometry, hemocytometer, and cell counting kit-8 assay, respectively. Results showed that exposure to RF-EMF at an SAR of 4.0 W/kg neither significantly induced γH2AX foci formation in A172, U251, or SH-SY5Y cells, nor resulted in abnormal cell cycle progression, cell proliferation, or cell viability. Furthermore, prolonged incubation of these cells for up to 48 h after exposure did not significantly affect cellular behavior. Our data suggest that 1800 MHz RF-EMF exposure at 4.0 W/kg is unlikely to elicit DNA damage or abnormal cellular behaviors in neurogenic cells. Bioelectromagnetics. 38:175-185, 2017. © 2016 Wiley Periodicals, Inc.

Automation of the in vitro micronucleus and chromosome aberration assay for the assessment of the genotoxicity of the particulate and gas-vapor phase of cigarette smoke.

Total particulate matter (TPM) and the gas-vapor phase (GVP) of mainstream smoke from the Reference Cigarette 3R4F were assayed in the cytokinesis-block in vitro micronucleus (MN) assay and the in vitro chromosome aberration (CA) assay, both using V79-4 Chinese hamster lung fibroblasts exposed for up to 24 h. The Metafer image analysis platform was adapted resulting in a fully automated evaluation system of the MN assay for the detection, identification and reporting of cells with micronuclei together with the determination of the cytokinesis-block proliferation index (CBPI) to quantify the treatment-related cytotoxicity. In the CA assay, the same platform was used to identify, map and retrieve metaphases for a subsequent CA evaluation by a trained evaluator. In both the assays, TPM and GVP provoked a significant genotoxic effect: up to 6-fold more micronucleated target cells than in the negative control and up to 10-fold increases in aberrant metaphases. Data variability was lower in the automated version of the MN assay than in the non-automated. It can be estimated that two test substances that differ in their genotoxicity by approximately 30% can statistically be distinguished in the automated MN and CA assays. Time savings, based on man hours, due to the automation were approximately 70% in the MN and 25% in the CA assays. The turn-around time of the evaluation phase could be shortened by 35 and 50%, respectively. Although only cigarette smoke-derived test material has been applied, the technical improvements should be of value for other test substances.

Evaluation of genotoxicity induced by repetitive administration of local anaesthetics: an experimental study in rats / Avaliação da genotoxicidade induzida pela administração repetida de anestésicos locais: um estudo experimental em ratos / Evaluación de la genotoxicidad inducida por la administración repetida de anestésicos locales: un estudio experimental en ratones

BACKGROUND AND OBJECTIVE: Previous studies regarding the effects of some local anaesthetics have suggested that these agents can cause genetic damage. However, they have not been tested for genotoxicity related to repetitive administration. The aim of this study was to evaluate the genotoxic potential of local anaesthetics upon repetitive administration. METHODS: 80 male Wistar rats were divided into: group A - 16 rats intraperitoneally injected with lidocaine hydrochloride 2%; group B - 16 rats IP injected with mepivacaine 2%; group C - 16 rats intraperitoneally injected with articaine 4%; group D - 16 rats IP injected with prilocaine 3% (6.0 mg/kg); group E - 8 rats subcutaneously injected with a single dose of cyclophosphamide; and group F - 8 rats intraperitoneally injected with saline. Eight rats from groups A to D received a single dose of anaesthetic on Day 1 of the experiment; the remaining rats were dosed once a day for 5 days. RESULTS: The median number of micronuclei in the local anaesthetics groups exposed for 1 or 5 days ranged from 0.00 to 1.00, in the cyclophosphamide-exposed group was 10.00, and the negative control group for 1 and 5 days was 1.00 and 0.00, respectively (p < 0.0001). A significant difference in the number of micronuclei was observed between the cyclophosphamide group and all local anaesthetic groups (p = 0.0001), but not between the negative control group and the local anaesthetic groups (p > 0.05). CONCLUSION: No genotoxicity effect was observed upon repetitive exposure to any of the local anaesthetics evaluated. .

JUSTIFICATIVA E OBJETIVOS: Estudos anteriores sobre os efeitos de alguns anestésicos locais sugeriram que esses agentes podem causar alterações genéticas. No entanto, esses agentes não são testados para genotoxicidade relacionada à administração repetida. O objetivo deste estudo foi avaliar o potencial genotóxico de anestésicos locais após repetidas administrações. MÉTODOS: 80 ratos Wistar machos foram alocados em: grupo A - 16 ratos receberam injeção por via intraperitoneal (IP) de cloridrato de lidocaína a 2%; grupo B - 16 ratos receberam injeção IP com mepivacaína a 2%; grupo C - 16 ratos receberam injeção IP de articaína a 4%; grupo D - 16 ratos receberam injeção IP de prilocaína a 3% (6 mg kg-1); grupo E - oito ratos receberam injeção subcutânea em dose única de ciclofosfamida; grupo F - oito ratos receberam injeção IP com solução salina. Oito ratos dos grupos de A a D receberam uma dose única de anestésico no Dia 1 da experiência; os ratos restantes foram dosados uma vez por dia durante cinco dias. RESULTADOS: A mediana do número de micronúcleos nos grupos com anestésicos locais expostos por um ou cinco dias variou de 0 a 1; no grupo exposto à ciclofosfamida foi de 10 e no grupo controle negativo no primeiro e quinto dias foi de 1 e 0, respectivamente (p < 0,0001). Uma diferença significativa foi observada no número de micronúcleos entre o grupo ciclofosfamida e todos os grupos com anestésicos locais (p = 0,0001), mas não entre o grupo controle negativo e os grupos com anestésicos locais (p > 0,05). CONCLUSÃO: Nenhum efeito de genotoxicidade foi observado após a exposição repetida a qualquer um dos anestésicos locais avaliados. .

JUSTIFICACIÓN Y OBJETIVOS: Estudios previos sobre los efectos de algunos anestésicos locales han mostrado que esos agentes pueden causar alteraciones genéticas. Sin embargo, esos agentes no son testados para la genotoxicidad relacionada con la administración repetida. El objetivo de este estudio fue evaluar el potencial genotóxico de anestésicos locales después de repetidas administraciones. MÉTODOS: 80 ratones Wistar machos se dividieron en: grupo A: 16 ratones que recibieron inyección por vía intraperitoneal (IP) de clorhidrato de lidocaína al 2%; grupo B: 16 ratones a los que se les administró inyección IP con mepivacaína al 2%; grupo C: 16 ratones que recibieron inyección IP de articaína al 4%; grupo D: 16 ratones a los que se les administró inyección IP de prilocaína al 3% (6 mg/kg); grupo E: 8 ratones que recibieron inyección subcutánea en dosis única de ciclofosfamida; grupo F: 8 ratones que recibieron inyección IP con solución salina. Ocho ratones de los grupos A a D recibieron una dosis única de anestésico el primer día de la experiencia; los ratones restantes se dosificaron una vez por día durante 5 días. RESULTADOS: La mediana del número de micronúcleos en los grupos con anestésicos locales expuestos durante uno o 5 días varió de 0 a 1; en el grupo expuesto a la ciclofosfamida fue de 10 y en el grupo control negativo en el primero y quinto día fue de 1 y 0 respectivamente (p < 0,0001). Se observó una diferencia significativa en el número de micronúcleos entre el grupo ciclofosfamida y todos los grupos con anestésicos locales (p = 0,0001), pero no entre el grupo control negativo y los grupos con anestésicos locales (p > 0,05). CONCLUSIÓN: Ningún efecto de genotoxicidad fue observado después de la exposición repetida a cualquiera de los anestésicos locales evaluados. .

Application of a modified gaseous exposure system to the in vitro toxicological assessment of tobacco smoke toxicants.

Tobacco smoke is a complex mixture of over 6,000 individual chemical constituents. Approximately 150 of these have been identified as 'tobacco smoke toxicants' due to their known toxicological effects. A number of these toxicants are present in the gaseous phase of tobacco smoke. This presents a technical challenge when assessing the toxicological effects of these chemicals in vitro. We have adapted a commercially available tobacco smoke exposure system to enable the assessment of the contribution of individual smoke toxicants to the overall toxicological effects of whole mainstream cigarette smoke (WS). Here we present a description of the exposure system and the methodology used. We use the example of a gaseous tobacco smoke toxicant, ethylene oxide (EtO), a Group 1 IARC carcinogen and known mutagen, to illustrate how this methodology can be applied to the assessment of genotoxicity of gaseous chemicals in the context of WS. In the present study we found that EtO was positive in Salmonella typhimurium strain YG1042, a strain that is sensitive to tobacco smoke. However, EtO did not increase the mutagenicity of the WS mixture when it was added at greatly higher concentrations than those found typically in WS. The findings presented here demonstrate the suitability of this exposure system for the assessment of the mutagenic potential of gases in vitro. Whilst we have focused on tobacco smoke toxicants, this system has broad application potential in studying the biological effects of exposure to a wide range of gaseous compounds that are present within complex aerosol mixtures.

A cell-based biosensor system HepG2CDKN1A-DsRed for rapid and simple detection of genotoxic agents.

The regulatory requirements for genotoxicity testing rely on a battery of genotoxicity tests, which generally consist of bacterial and mammalian cell assays for detection of gene mutations and chromosomal aberrations. However, for rapid screening, these methods are not appropriate. We have developed a new cell-based biosensor system that provides rapid and simple detection of genotoxic substances. This is based on stable transfection of human hepatoma HepG2 cells with a plasmid that encodes the red fluorescent protein DsRed2 under the control of the CDKN1A promoter (HepG2CDKN1A-DsRed cells). As the major downstream target gene of activated TP53, the tumour-suppressor gene CDKN1A is responsible for cell-cycle arrest following DNA damage, and it has been shown to be specifically up-regulated by genotoxic carcinogens. The assay is optimised for a 96-well microplate format and spectrofluorimetric quantification of induced DsRed expression. The assay was evaluated by testing direct-acting and indirect-acting genotoxic compounds with different mechanisms of action, along with non-genotoxic compounds. Out of 25 compounds that are known to be genotoxic in vitro and in vivo, 21 (84%) are detected as positive at non-cytotoxic doses, whereas of 12 compounds not considered genotoxic, 11 (92%) are negative. These data indicate the high sensitivity and specificity of our biosensor system. Based on its simplicity and sensitivity, this biosensor developed with HepG2CDKN1A-DsRed cells has the potential to become a valuable tool for genotoxicity screening for chemical safety evaluation, as well as for environmental and occupational monitoring of exposure to genotoxic agents and their complex mixtures.

Comparative analysis of clastogen-induced chromosome aberrations observed with light microscopy and by means of atomic force microscopy.

Different types of chromosome aberration were observed in mouse bone-marrow cells after treatment with 4-bromo-N,N-diethyl-5,5-dimethyl-2,5-dihydro-1,2-oxaphosphol-2-amine 2-oxide (Br-oxaphosphole, Br-oxph) in a previous study. The aim of the present study is to perform a comparative analysis of these chromosomal damages observed with light microscopy (LM) and by means of atomic force microscopy (AFM). The kinds of aberrations scored by LM were substantially corrected by images at the ultrastructural level. The AFM analysis excluded 29.0% of gaps and 33.3% of fusion-type aberrations. On the other hand, AFM revealed the presence of aberrations that were not visible under the LM. This indicates that only AFM images would provide precise information about the real nature of chromosomal damages. The results of our study revealed that the 'real gaps' represented about 50% of all the gaps visible under LM. Excluded 'false gaps' were detected via AFM as breaks or decondensed chromosome regions. These results would support the statement that gaps must be included when testing genotoxicity. The ultrastructural analysis also confirmed the validity of using LM in the mouse bone-marrow chromosome aberration test, as a tool for detecting genotoxicity of chemicals in routine studies. When there is a need for precise evaluation of chromosome damage, only AFM images can provide information on specific genotoxic effects.

Sensitive detection of chemical-induced genotoxicity by the Cypridina secretory luciferase reporter assay, using DNA repair-deficient strains of Saccharomyces cerevisiae.

Yeast-based reporter assays are useful for detecting various genotoxic chemicals. We established a genotoxicity assay using recombinant strains of Saccharomyces cerevisiae, each containing a reporter plasmid with the secretory luciferase gene from Cypridina noctiluca, driven by a DNA damage-responsive promoter of the yeast RNR3 gene. This system detected the genotoxicity of methyl methanesulphonate (MMS) as sensitively as conventional yeast-based reporter assays, using the ß-galactosidase gene in a concentration-dependent manner; it also detects four other genotoxic chemicals, allowing us to monitor DNA damage easily by skipping the cell extraction process for the assay. We examined Cypridina luciferase levels induced by MMS and three antitumour agents using a set of BY4741-derived deletion mutants, each defective in a DNA repair pathway or DNA damage checkpoint. Luciferase activities were particularly enhanced in mutant strains with mms2 Δ and mag1 Δ by exposure to MMS, rad59 Δ and mlh1 Δ to camptothecin and mms2 Δ and mlh1 Δ to mitomycin C, respectively, compared with their parent strains. Enhanced reporter activities were also found in some DNA repair mutants with cisplatin. These observations suggest that this Cypridina secretory luciferase reporter assay using yeast DNA repair mutants offers convenient and sensitive detection of the potential genotoxicity of numerous compounds, including antitumour drugs and studying the mechanisms of DNA damage response in yeast.

Mutagenicity evaluation with Ames test of hydro-alcoholic solution of terpenes.

Mutagenic properties of terpenes (both synthesis and plant derived) have been tested, up to now, as a single molecule. A terpenes containing hydro-alcoholic solution deriving from frankincense and myrrh resins and hyssop essential oil was assayed for mutagenicity by means of ames test. Extraction technique conducted with electromagnetic fields at room temperature enabled to obtain a solution of free active molecules that did not undergo thermal degradation and characterized by biocidal activity. In order to verify lack of mutagenic hazard in coming into contact with human, the solution was appropriately diluted and tested with Salmonella typhimurium TA98, TA1535 and YG1024 strains, both in absence and in presence of metabolic system S9. For none of the tested conditions a 2-fold increase of induced revertants, as regards to spontaneous, was registered. The ratio between induced and spontaneous His+ revertants (Mutagenic Index) was around 1.00 in all the determinations and no statistically significant differences have been identified comparing the sample and the negative control. A similar result has been obtained for the dose-response curve. In conclusion, we verified that tested terpenes solution lacks of mutagenicity on Salmonella typhimurium with and without metabolic activator so this plant extract can be safely used as biocide.

Deletion of MAG1 and MRE11 enhances the sensitivity of the Saccharomyces cerevisiae HUG1P-GFP promoter-reporter construct to genotoxicity.

Eukaryotic yeast-based DNA damage cellular sensors offer many advantages to traditional prokaryotic-based mutagenicity assays. The HUG1P-GFP promoter-reporter construct has proven to be an effective method to selectively screen for multiple types of DNA damage. To enhance the sensitivity and selectivity of the system to different types of DNA damage, two genes involved in distinct DNA damage responses were deleted. Deletion of MAG1, a gene encoding a DNA glycosylase and member of the base excision repair (BER) pathway, increased the biosensor's sensitivity to the alkylating agents methyl methanesulfonate (MMS) (lowering the sensitivity threshold to 0.0001% (v/v)) and ethyl methanesulfonate (EMS). Deletion of MRE11, part of the highly conserved RMX complex that aids in sensing and repairing double strand breaks in budding yeasts, enhanced sensitivity to gamma radiation (gamma-ray) (detection threshold of 50Gy) and camptothecin. The mre11Delta phenotype dominated in mag1Deltamre11Delta strains. Through the deletions, we were able to engineer increased selectivity to alkylating agents, gamma-ray, and camptothecin, since increased sensitivity to one type of damage did not alter the quantitative response to other genotoxins. The enhancements to the HUG1P-GFP system did not affect its ability to detect several other DNA damaging agents, including 1,2-dimethyl hydrazine (SDMH), phleomycin, and hydroxyurea (HU), or affect its lack of response to the potentially non-genotoxic carcinogen formaldehyde.

An improved system for exposure of cultured mammalian cells to gaseous compounds in the chromosomal aberration assay.

A gas exposure system using rotating vessels was improved for exposure of cultured mammalian cells to gaseous compounds in the chromosomal aberration assay. This system was composed of 12 square culture vessels, a device for preparation of air containing test gas, and positive and negative control gases at target concentrations and for supplying these gases to the culture vessels, and a roller apparatus in an incubator. Chinese hamster lung cells (CHL/IU) were grown on one side of the inner surface of the square culture vessel in the MEM medium. Immediately prior to exposure, the medium was changed to the modified MEM. Air in the culture vessel was replaced with air containing test gas, positive or negative control gas. Then, the culture vessels were rotated at 1.0 rpm. The monolayered culture cells were exposed to test gas during about 3/4 rotation at upper positions and alternatively immersed into the culture medium during about 1/4 rotation at lower positions. This system allowed the chromosomal aberration assay simultaneously at least at three different concentrations of a test gas together with positive and negative control gases with and without metabolic activations, and duplicate culture at each exposure concentration. Seven gaseous compounds, 1,3-butadiene, chlorodifluoromethane, ethyl chloride, methyl bromide, methyl chloride, propyne, and vinyl chloride, none of which has been tested to date, were tested on CHL/IU for the chromosomal aberration assay using this gas exposure system. All the compounds except chlorodifluoromethane showed positive responses of the structural chromosomal aberrations, whereas polyploidy was not induced by any of these gases. This improved gas exposure system proved to be useful for detecting chromosomal aberrations of gaseous compounds.

A modified Ames assay reveals the mutagenicity of native cigarette mainstream smoke and its gas vapour phase.

The evaluation of the mutagenic activity of cigarette smoke is mostly based on studies with condensates or extracts in the standard Ames assay. These samples only insufficiently reflect the composition of the actual generated aerosol. Therefore, such atmospheres should be analysed in their native composition to gain a real signal of its mutagenic capacity. Based on the technical difficulties of testing native air contaminants, there are no accepted methods for effective exposure of bacteria under such conditions. Therefore, we established a new experimental approach for direct exposure of bacteria in a modified CULTEX system (Patent no. DE 19801763/PCT/EP99/00295) connected to a smoking machine. This allowed us to investigate the mutagenic activity of native mainstream smoke of the research cigarette K2R4F by exposure of Salmonella Typhimurium strains. In comparison to studies using the plate incorporation assay, the direct exposure of bacteria to smoke on the agar surface enhances contact to the aerosols. By using this modification of the Ames assay, we demonstrate that it is possible to analyse the effects of native whole smoke and the gas vapour phase of cigarettes directly and achieve a dose-dependent induction of revertants. In a number of experiments, the treatment of strains TA98 and TA100 with whole smoke and the gas vapour phase of K2R4F cigarettes resulted in the induction of revertants dependent on the dilution of smoke and the number of cigarettes smoked. Our alternative procedure of exposing bacteria directly to gases and complex mixtures offers new possibilities in the field of inhalation genotoxicology for the evaluation of genotoxicity in the Ames assay.

Evaluación de riesgo genotóxico: biomonitorización de trabajadores agrícolas de Caranavi, Guanay, Palca y Mecapaca, expuestos a plaguicidas / Assessment of genoptoxic risk biomonitoring of farm workers exposed to pesticides in Caranavi, Guanay, Palca and Mecapaca

OBJETIVO: detectar los efectos citotóxicos y genotóxicos en trabajadores agrícolas, mediante estudios de biomonitoreo genético. DISEÑO: casos y controles Participantes Trabajadores agrícolas de Caranavi, Guanay, Mecapaca y Palca del Departamento de La Paz Lugar Localidades de Caranavi, Guanay, Palca y Mecapaca. Unidad de Genética, toxicológica Instituto de Genética MATERIAL Y MÉTODOS: se aplicó cuestionario a 259 trabajadores agrícolas. Se evaluó el efecto genotóxico en linfocitos de sangre heparinizada, a través de la frecuencia de Intercambios entre Cromátides Hermanas (ICH), el Índice de Proliferación Celular (PRI), el % de células con alta frecuencia de intercambios (%HFC), frecuencia de micronúcleos en células binucleadas (MNBN), el índice de división nuclear (IDN), la presencia de aberraciones cromosómicas estructurales (AC), y parámetros de la prueba del cometa, como DNA de la cola, DNA de la cabeza, longitud de la cola, longitud del cometa, el momento de la cola y momento Olive. RESULTADOS: Los casos presentaron un aumento estadísticamente significativo (p<0.05) en la frecuencia de ICH, MN/BN y aberraciones cromosómicas, en relación a los controles. Así mismo, los parámetros de DNA de la cola, DNA de la cabeza, longitud de la cola, longitud del cometa, el momento de la cola y momento Olive, mostraron un aumento en relación a los controles, (p<0.05). Los valores promedio (± ES) de los parámetros del ensayo del cometa, fueron mayores y estadísticamente significativos en los expuestos y RPP's en relación a los no expuestos. En el grupo de RPP´s se observó daño genotóxico en menor proporción pero no significativo en relación a los expuestos, posiblemente por su capacitación en medidas de protección. El análisis divariado entre exposición a plaguicidas y daño genotóxico mostró que las personas expuestas a plaguicidas tienen 1.49 veces más probabilidad de sufrir daño genotóxico con un OR de 2.49 (IC 95% 1.48 - 4.20). CONCLUSIÓN: los resultados indican que los trabajadores agrícolas expuestos sin protección ni medidas de seguridad a mezclas de plaguicidas, han experimentado riesgo genotóxico, que fue manifestado con elevada frecuencia de intercambios entre cromátides hermanas, micronúcleos, aberraciones cromosómicas y parámetros del cometa, en linfocitos de sangre periférica. Así mismo, la presencia de aberraciones cromosómicas, que son las que determinan la asociación con efecto carcinogénico, muestra que los trabajadores agrícolas expuestos a plaguicidas tienen mayor probabilidad de que las mutaciones encontradas al momento del estudio, puedan volverse irreversibles por la saturación de los sistemas de reparación del DNA y en el futuro desarrollar diversos tipos de cáncer. Estos hallazgos son indicativos de la necesidad de realizar biomonitorización permanente de los agricultores ocupacionalmente expuestos a varias mezclas de plaguicidas, utilizando una batería de pruebas de genotoxicidad. Por otra parte, ilustra la necesidad de implementar pautas generales para minimizar o prevenir la exposición.

OBJECTIVE: to detect the cytotoxic and genotoxic effects in farm workers, by means of genetic biomonitoring studies. Design Cases and controls Participants Farm workers from Caranavi, Guanay, Palca and Mecapaca Place Towns of Caranavi, Guanay, Palca and Mecapaca, Genetic Toxicology unit. Genetic Institute. MATERIAL AND METHODS: Questionnaires to 257 agricultural workers were applied genotoxic effect was evaluated in lymphocytes from heparinized blood, through analysis of sister chromatid Exchange (SCE), cells with a high frecuency of SCE (HFC), proliferation rate index (PRI) the micronucleus (MN) assay, nuclear division index (NDI), chromosomal aberrations (CA) and comet assay parameters like DNA tail, DNA head, tail length comet length, tail moment and Olive moment. RESULTS: the frequency of SCE, MN/BN and CA was significantly increased (p<0.05) in cases vs. control group. Likewise, the parameters of Tail DNA, DNA head , tail length, comet length, tail moment and Olive moment, showed increased values in relation to controls (p<0.05). Averages of comet parameters were significantly higher in exposed and RPP's group than in un exposed group. RPP`s groups showed minor DNA damage but not as significant as exposed group, possibly due to their training in protective measures. The bivariated analysis between pesticides exposure and genotoxic damage showed that the people exposed to pesticides have 1.49 times more probability of suffering genotoxic damage with OR 2.49 (IC 95% 1.48 - 4.20). CONCLUSIONS: the results indicate that the farm workers exposed to mixture of pesticides without protection and safety measures, are at genotoxic risk hazard , with high frequency of sister chromatid exchange, micronuclei, chromosomal aberrations and parameters of the comet assay in lymphocytes of peripheral blood. Also, the presence of chromosomal aberrations, which are those that determine the association with carcinogenic effect, shows that the farm workers exposed to pesticides have greater probability that the mutations found at the time of the study, can become irreversible by saturation of the DNA repair systems and in the future develop diverse types of cancer. These findings are indicative of the necessity to do permanent biomonitoring of the farmers occupationally exposed to several mixtures of pesticides, using a battery of genotoxicity tests. On the other hand, it illustrates the necessity to implement general guidelines to diminish or to prevent the exposure.

A modified CULTEX system for the direct exposure of bacteria to inhalable substances.

Increasing attention is being paid to the impact on human health of inhaled gaseous compounds and complex mixtures such as cigarette smoke. The evaluation of the genotoxicity of such materials is mostly based on experiments with model substances or mixtures and condensates in the standard Ames assay. Due to the methodological difficulties of testing air contaminants in their natural gaseous or aerosolised state, there are no generally accepted concepts and techniques for effective exposure of bacteria under such conditions. Therefore, we established a novel experimental approach using an exposure device based on the cell exposure system CULTEX. This allows us to investigate chemically and physically unchanged atmospheres like mainstream cigarette smoke by exposing bacteria of Salmonella typhimurium strains directly on the surface of culture media. The CULTEX exposure device can be connected to gas or aerosol generating systems. The introduction of this exposure device in the field of inhalation genotoxicology offers new test strategies for the in vitro evaluation of a wide range of inhalable substances in both laboratory and ambient situations. A patent was applied for this technical solution.